Could advancements in non-invasive imaging techniques further enhance our ability to monitor these changes in response to incretin therapies and lifestyle interventions?
These assumptions were used in lieu of clinical data informing changes in HbA1c and BMI on initiation of SGLT-2 inhibitor or basal insulin therapy in populations previously receiving metformin and GLP-1 receptor agonist therapy, and this remains the key limitation in modelling more complex treatment algorithms for type 2 diabetes
By reducing stomach acid, omeprazole may alter how long semaglutide takes to move through the digestive system and reach parts of the body where it needs to work
It now includes oral GLP-1 drugs, amylin combinations, dual agonists, triple agonists, long-acting platforms, and differentiated assets designed for durability, tolerability, access, or broader metabolic indications
Vein Damage: Frequent IV use can cause vein damage or scarring